These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Valvular heart disease in women: the surgical perspective. Carpenter AJ; Camacho M J Thorac Cardiovasc Surg; 2004 Jan; 127(1):4-6. PubMed ID: 14752404 [No Abstract] [Full Text] [Related]
6. Valvular heart disease and the military patient. Holdsworth DA; Mulae J; Williams A; Jackson S; Chambers J J R Army Med Corps; 2015 Sep; 161(3):223-9. PubMed ID: 26240189 [TBL] [Abstract][Full Text] [Related]
7. [Epidemiology and etiology of acquired heart valve diseases in adults]. Lucas G; Tribouilloy C Rev Prat; 2000 Oct; 50(15):1642-5. PubMed ID: 11116603 [TBL] [Abstract][Full Text] [Related]
8. Prevalence & composition of heart valve multi-disciplinary teams within a national health system. Bhattacharyya S; Pavitt C; Lloyd G; Chambers JB; Int J Cardiol; 2014 Dec; 177(3):1120-1. PubMed ID: 25171971 [No Abstract] [Full Text] [Related]
9. [Incidence and distribution of valvular diseases in the aged--clinical observations on 206 cases of persons over 60 years of age. (I)]. Ueda H; Sakamoto T; Uozumi Z; Kawai N; Yamada T Saishin Igaku; 1967 Oct; 22(10):2307-10. PubMed ID: 5588195 [No Abstract] [Full Text] [Related]
10. [Moderate or severe aquired valvular heart disease in pregnancy--what does determine the management? Experence, intuition or guidelines?]. Greszata L; Stępińska J Przegl Lek; 2015; 72(4):189-92. PubMed ID: 26455017 [TBL] [Abstract][Full Text] [Related]
11. The year in valvular heart disease. Rahimtoola SH J Am Coll Cardiol; 2007 Jan; 49(3):361-74. PubMed ID: 17239719 [No Abstract] [Full Text] [Related]
12. [Non-rheumatic multivalvular regurgitation in an older population: a pulsed Doppler echocardiographic study]. Sugita I; Yoshikawa J; Yoshida K; Kato H; Yanagihara K; Koizumi K; Okumachi F; Shiratori K; Asaka T; Akasaka T J Cardiogr; 1986 Jun; 16(2):427-32. PubMed ID: 3585068 [TBL] [Abstract][Full Text] [Related]
13. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology. Bonow RO; Nishimura RA; Thompson PD; Udelson JE; Circulation; 2015 Dec; 132(22):e292-7. PubMed ID: 26621646 [No Abstract] [Full Text] [Related]
15. Burden of valvular heart diseases: a population-based study. Nkomo VT; Gardin JM; Skelton TN; Gottdiener JS; Scott CG; Enriquez-Sarano M Lancet; 2006 Sep; 368(9540):1005-11. PubMed ID: 16980116 [TBL] [Abstract][Full Text] [Related]
16. Influence of sociodemographic and clinical characteristics at the impact of valvular heart disease. dos Anjos DB; Rodrigues RC; Padilha KM; Pedrosa RB; Gallani MC Rev Bras Enferm; 2016; 69(1):33-9. PubMed ID: 26871213 [TBL] [Abstract][Full Text] [Related]